Sleeping Pills Can Increase Risk Of Traffic Accidents
Main Category: Sleep / Sleep Disorders / InsomniaAlso Included In: Public Health
Article Date: 08 Feb 2008 - 2:00 PDT
| Patient / Public: | ![]() |
4.5 (2 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
Benzodiazepine-like hypnotics (z-hypnotics) are commonly used in Norway with a general understanding that they do not affect daily performance. However, researchers at the Norwegian Institute of Public Health (NIPH) have now found an increased risk of being involved in a road traffic accident after a patient has been dispensed this type of prescribed hypnotic. The risk can be compared with that for other hypnotics such as nitrazepam.
The study was carried out based on data from three different registers and covered various hypnotics; zopiclone (Imovane®), zolpidem (Stilnoct®), nitrazepam (Apodorm®, Mogadon®) and flunitrazepam (Flunipam®, Rohypnol®). The occurrence of accidents in the period after a hypnotic drug was dispensed (exposed period) was compared with the occurrence of accidents in the non-exposed period.
A clearly increased risk for traffic accidents was observed for the first week after prescriptions of the fore-mentioned hypnotics were dispensed. The risks after dispensing zopiclone, zolpidem and nitrazepam were comparable and increased over twice as much compared with non-exposed periods. For flunitrazepam the incidence risk was raised by 4-fold. These new results are alarming because zopiclone and zolpidem are considered to not affect driving ability the following day when taken correctly in therapeutic doses before bedtime. The study therefore indicates that driving should be reduced in periods where people are exposed to these drugs.
Link to published article (abstract): Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel I, Morland J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008; Click here.
Norwegian Institute of Public Health
Visit our sleep / sleep disorders / insomnia section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/96633.php>
APA
http://www.medicalnewstoday.com/releases/96633.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




